Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying? - Wikidata - wikimedia - TriplyDB

Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

http://www.wikidata.org/entity/Q37762792

about

Withdrawal or continuation of cholinesterase inhibitors and/or memantine in patients with dementia Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.Managing medications in clinically complex elders: "There's got to be a happy medium".Potentially suboptimal prescribing for older veteran nursing home patients with dementia.Five skills psychiatrists should have in order to provide patients with optimal ethical care.Antibiotic use and associated factors in patients with dementia: a systematic review.End-of-life issues in advanced dementia: Part 2: management of poor nutritional intake, dehydration, and pneumonia.Systems to identify potentially inappropriate prescribing in people with advanced dementia: a systematic review.Year in review: medication mishaps in the elderly.Use of medications of questionable benefit in advanced dementia.Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia The challenges of providing palliative care for older people with dementia.Drug therapy optimization at the end of life.Noncomfort medication use in acute care inpatients comanaged by palliative care specialists near the end of life: a cohort study.Medication use and potentially inappropriate medications in those with limited prognosis living in residential aged care.Exploring the enablers and barriers to implementing the Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria in Australia: a qualitative study.Palliative care for people with dementia: a literature review.Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database.Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France.Development and Validation of the Revised Patients' Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers.Advanced dementia in a sample of Brazilian elderly: Sociodemographic and morbidity analysis.Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.Prescribing for older people in nursing homes: challenges for the future.Development and application of medication appropriateness indicators for persons with advanced dementia: a feasibility study.Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel.Assessment of factors that influence physician decision making regarding medication use in patients with dementia at the end of life.Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study.Antiretroviral therapy at the end of life: the experience of an academic HIV clinic.Age, dementia and care patterns after admission for acute coronary syndrome: an analysis from a nationwide cohort under the National Health Insurance coverage.A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia.Withdrawal of Antidementia Drugs in Older People: Who, When and How?End-of-life decisions in individuals dying with dementia in Belgium.End of life care: The experiences of advance care planning amongst family caregivers of people with advanced dementia - A qualitative study.Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review.Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study.Neuropsychiatric symptoms of dementia: consent, quality of life, and dignity.Enjeux de fin de vie dans les cas de démence avancée: 2e partie : prise en charge de l’apport nutritionnel insuffisant, de la déshydratation et de la pneumonie.

P2860

Q24235324-1EA4E07D-FAC2-4C88-B0E9-F86576318294 Q26997299-2B5E129D-0002-4CE0-AB55-AB294E0546F9 Q33165801-F8D62C15-CCB8-4B9F-95E3-A3B29344A0F2 Q33427274-0F9BCF7B-9E18-40F4-AF42-084F56A56D35 Q34311242-49AFD098-6D81-4D30-9CB9-49236E21C8AB Q34747234-99BFDC31-F9E3-49D0-A152-886D39C6D789 Q34779702-1B3637BB-4F69-456B-B06D-405D9B8E354F Q35408929-25617FFC-9AE0-4511-8914-EA47114B43CE Q35412780-669A6459-D25C-45C9-B612-7B720D3278CF Q36035333-DFA391BA-1A36-4CDE-954A-BF1130F621EE Q36278264-8EC20678-DA20-4763-B9D9-98EA631D6655 Q36398853-E8D22062-5D9F-4645-9CDA-030C029476B8 Q36826416-D2E291FB-FE5C-41FE-9719-76213F72F5DF Q37866665-A4884EE2-2A17-417D-8133-E6DD326CE6CE Q38014128-745D9E7C-8170-4F4D-8998-0F7B7BA4D155 Q38148462-4B058EB8-5135-4D49-834E-E5C69393F3CF Q38594870-47E8FB55-46E7-4873-87D5-2B110749A36D Q38609516-54B5F401-318D-4CFA-93F0-826B11BE5470 Q38754742-A6C17A33-161D-4D15-B113-F15E7B8A134C Q38881079-0EC3EADD-E184-4857-B2EF-515BA267B07A Q38908925-C3E26B44-6D40-4190-9BC2-C3B7C95E5135 Q38992164-25EAA142-92D5-4CFC-ABA5-4C26325B2C67 Q39089353-AE081D14-5679-4FE1-82EB-2C619C77A34E Q39657233-8E7E7F1F-D497-4F89-88BA-AB398E958C99 Q39706971-CE73671A-7F20-42BB-9EBC-ABB0F20F2E17 Q39785101-791810FB-0F86-466C-AF78-F06687D047F8 Q41722511-BBA1DAE3-AA20-4C91-A406-CA25DF8EFF1E Q42361327-F2F2C6C5-FC66-4CE5-8817-ADCB2CA07656 Q42608010-742EB726-3B12-41FF-9A75-8FC7475CEE25 Q43623168-8F6BD59A-4775-4691-AF27-51C7FDC06A35 Q44201884-CEBD64B2-CB90-4F15-8C85-6FB15BDFEF64 Q44964186-FF5AB007-05CA-45BA-AFE3-8F4D19AA3311 Q47571627-D3993DCE-CEC3-4277-BBB3-04EB5E65A4F1 Q48167336-77FA27BC-BD08-4DBA-87A4-8C99EA4D2203 Q49160617-0F790945-734B-4DD9-AA85-09F3BA2EF669 Q51794470-B3E57322-5C30-48AE-97CD-FFF90A117935 Q51800071-35334F13-A1AA-4A21-8D0C-6E883F87CFDF Q52625059-DCB584AA-3987-48C7-BB8B-72B47348F5DE Q52933114-46A04618-3606-43DD-8CD8-1777DA30173C Q55084757-84A3C54E-63A9-4BC8-AAD2-B7EA097F9D8E

P2860

Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

http://www.wikidata.org/entity/Q37762792

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Withholding, discontinuing and ...... em in the disadvantaged dying?

@en

Withholding, discontinuing and ...... em in the disadvantaged dying?

@nl

type

label

Withholding, discontinuing and ...... em in the disadvantaged dying?

@en

Withholding, discontinuing and ...... em in the disadvantaged dying?

@nl

prefLabel

Withholding, discontinuing and ...... em in the disadvantaged dying?

@en

Withholding, discontinuing and ...... em in the disadvantaged dying?

@nl

P1433

Q37762792-41F4DD41-3C65-4E7E-AEF5-C62F144F8C94

P1476

Q37762792-AD8C6FB7-CDF0-43EF-8F03-D53EF466B295

P2093

Q37762792-0EEF5895-B24D-4D53-805F-60F4CB46F7DE

Q37762792-2B223B63-5016-43C0-A2F9-561BD0414ECF

Q37762792-CBA76D71-BF90-400B-8A68-400D5B1D82E0

Q37762792-DC2FFF3B-1DD7-4001-990F-DB31C3C4F147

P2860

Q37762792-1508646C-3E58-4B6D-A689-477D1BBE4719

Q37762792-2D0823A5-B1C5-43A4-9663-1B3B3285DFAD

Q37762792-2D703691-3C64-4A8B-BE87-82A80E6F9992

Q37762792-3697947C-A1EB-4A6E-B6D3-3E095BB06FD6

Q37762792-3D0AB834-C27C-436B-9E23-C90B5D7EE5BB

Q37762792-AC039901-2F0C-408A-A009-2872FB469A56

Q37762792-BAC1D0CC-081E-4414-AAE7-87F695865C6C

Q37762792-C719DC81-DBE8-4C3D-A741-F65AD0923B3D

Q37762792-DE22B281-DF51-43A8-B385-99E426734C4E

P2888

Q37762792-F7CF3005-2793-4EE7-87C6-1EC3AFD891C1

P304

Q37762792-D5BCF76E-477C-48F7-92AA-2AF16BD3BFE5

P31

Q37762792-903AA016-6443-4286-AAE8-28F8C7550CDC

P356

Q37762792-935C53B1-132F-43E1-975B-73BD7956CDBC

P433

Q37762792-B624D267-2643-4709-9A24-7077F60BF5A5

P478

Q37762792-31FCBCC1-28C5-4070-99FD-8982D78ECA6B

P577

Q37762792-BC30E393-8DB2-49F7-93B2-468E73CD07A3

P6179

Q37762792-A7052152-FD13-4463-A77F-80D54A11C8CA

P698

Q37762792-C1B15C44-3B0B-4D68-A312-A90FAC958B46

P921

Q37762792-0CB64889-969C-4135-8118-BD860CBE60ED

Q37762792-4A606DF6-5A2F-451D-AB16-F0075D55EF31

P356

11536760-000000000-00000

P1433

P1476

Withholding, discontinuing and ...... em in the disadvantaged dying?

@en

P2093

A Peter Passmore

http://www.w3.org/2001/XMLSchema#string

Carmel M Hughes

http://www.w3.org/2001/XMLSchema#string

Carole Parsons

http://www.w3.org/2001/XMLSchema#string

Kate L Lapane

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of special care unit for patients with advanced Alzheimer's disease on patients' discomfort and costs.

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.

Antipsychotic drug use and mortality in older adults with dementia.

Palliative fever management in Alzheimer patients. quality plus fiscal responsibility.

Predicting short-term survival for patients with advanced Alzheimer's disease.

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Correlates and management of nonmalignant pain in the nursing home. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.

Lower respiratory infections in nursing home residents with dementia: a tale of two countries.

Access to hospice programs in end-stage dementia: a national survey of hospice programs.

P2888

11536760-000000000-00000

P304

435-449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11536760-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024239824

http://www.w3.org/2001/XMLSchema#string

P698

20524704

http://www.w3.org/2001/XMLSchema#string

P921